These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 365433)

  • 61. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
    Helgeland A; Strømmen R; Hagelund CH; Tretli S
    Lancet; 1986 Apr; 1(8486):872-5. PubMed ID: 2870352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dependence of arterial pressure on intravascular volume in treated hypertensive patients.
    Dustan HP; Tarazi RC; Bravo EL
    N Engl J Med; 1972 Apr; 286(16):861-6. PubMed ID: 5061070
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effect of triamterene on serum potassium and serum creatinine in long-term treatment with thiazides].
    Dorph S; Oigaard A
    Nord Med; 1968 Apr; 79(16):516-8. PubMed ID: 5657636
    [No Abstract]   [Full Text] [Related]  

  • 65. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
    Schnaper HW; Maxwell MH
    Am J Cardiol; 1989 Jan; 63(4):32B-36B. PubMed ID: 2643290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients.
    Fogari R; Zoppi A; Malamani GD; Marasi G; Vanasia A; Villa G
    Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
    Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
    Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Renal physiology and the treatment of hypertension.
    Cade R; Juncos L; Tarrant D; Mahoney J; Raulerson D
    Compr Ther; 1977 Jan; 3(1):41-7. PubMed ID: 318955
    [No Abstract]   [Full Text] [Related]  

  • 70. Long term effect of timolol and hydrochlorothiazide, or hydrochlorothiazide and amiloride, in essential hypertension.
    Castenfors H
    Eur J Clin Pharmacol; 1977 Oct; 12(2):97-103. PubMed ID: 336379
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
    Woo J; Woo KS; Vallance-Owen J
    Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
    [No Abstract]   [Full Text] [Related]  

  • 72. The PACT study: post-marketing surveillance in 47,465 patients treated with Maxzide (triamterene/hydrochlorothiazide). An interim report.
    Hollenberg NK; Bannon JA
    Am J Med; 1986 Apr; 80(4A):30-6. PubMed ID: 3518430
    [No Abstract]   [Full Text] [Related]  

  • 73. Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.
    Kohvakka A; Salo H; Gordin A; Eisalo A
    Acta Med Scand; 1986; 219(4):381-6. PubMed ID: 3521208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. European Working Party on High Blood Pressure in the Elderly (EWPHE).
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):300-34. PubMed ID: 3896176
    [No Abstract]   [Full Text] [Related]  

  • 75. [Objectives and methods in therapy of essential arterial hypertension].
    Zanchetti A
    Cardiol Prat; 1968 Aug; 19(4):263-6. PubMed ID: 5746811
    [No Abstract]   [Full Text] [Related]  

  • 76. Ethacrynic acid alone and in combination with methyldopa in the management of mild hypertension. A report of 23 patients.
    Gifford RW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):255-60. PubMed ID: 4917428
    [No Abstract]   [Full Text] [Related]  

  • 77. Double-blind assessment of tienilic acid in essential hypertension.
    Freis ED
    Postgrad Med J; 1979; 55 Suppl 3():92-7. PubMed ID: 388402
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification.
    Amery A; Birkenhäger W; Brixko P; Bulpitt C; Clement D; de Leeuw P; de Plaen JF; Deruyttere M; De Schaepdryver A; Dollery C
    J Hypertens Suppl; 1986 Dec; 4(6):S642-7. PubMed ID: 3475430
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An evaluation of tienilic acid, a new diuretic uricosuric agent, in the therapy of arterial hypertension.
    Lechi A; Covi G; Danti G; Riva AD; Pedrolli E; Pomari S
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():367s-269s. PubMed ID: 396083
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolic and hypotensive effects of ethacrynic acid. Comparative study with hydrochlorothiazide.
    Russell RP; Lindeman RD; Prescott LF
    JAMA; 1968 Jul; 205(1):81-5. PubMed ID: 5694972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.